Home Orbio

Orbio

In operation
-
Cancer Diagnosis and Treatment Drug Developer
Basic
Enterprise Profile

Basic Information

ORBIO Corporation Develops and Deploys Unprecedented Cancer Diagnosis and Treatment Methods Using L-Glucose as a Lead Molecule, Integrating Knowledge from Medicine, Biology, Chemistry, and Physics. Collaborating with Scientists Utilizing New Knowledge Related to L-Glucose, ORBIO Corporation Will Provide a New Approach to Controlling Cancer.
ORBIO Corporation
Kyoto,Kyoto,Japan
less than 15 people
April 01, 2018
--

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Targeted Technology
Concept
Disease Diagnosis Disease Treatment Tumor
Application Scenarios
Targeted drugs Innovative Drugs